"von Willebrand Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor.
| Descriptor ID |
D014841
|
| MeSH Number(s) |
D12.776.124.125.920 D23.119.985
|
| Concept/Terms |
von Willebrand Factor- von Willebrand Factor
- Factor VIIIR-Ag
- Factor VIIIR Ag
- Factor VIIIR-RCo
- Factor VIIIR RCo
- Ristocetin-Willebrand Factor
- Ristocetin Willebrand Factor
- von Willebrand Protein
- Factor VIII-Related Antigen
- Factor VIII Related Antigen
- Ristocetin Cofactor
|
Below are MeSH descriptors whose meaning is more general than "von Willebrand Factor".
Below are MeSH descriptors whose meaning is more specific than "von Willebrand Factor".
This graph shows the total number of publications written about "von Willebrand Factor" by people in this website by year, and whether "von Willebrand Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 4 | 5 |
| 1995 | 3 | 0 | 3 |
| 1996 | 1 | 1 | 2 |
| 1997 | 3 | 2 | 5 |
| 1998 | 3 | 4 | 7 |
| 1999 | 0 | 1 | 1 |
| 2000 | 2 | 1 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 3 | 4 | 7 |
| 2003 | 8 | 3 | 11 |
| 2004 | 6 | 0 | 6 |
| 2005 | 2 | 2 | 4 |
| 2006 | 2 | 5 | 7 |
| 2007 | 3 | 3 | 6 |
| 2008 | 3 | 1 | 4 |
| 2009 | 4 | 1 | 5 |
| 2010 | 4 | 2 | 6 |
| 2011 | 3 | 2 | 5 |
| 2012 | 2 | 0 | 2 |
| 2013 | 9 | 2 | 11 |
| 2014 | 7 | 0 | 7 |
| 2015 | 7 | 4 | 11 |
| 2016 | 0 | 3 | 3 |
| 2017 | 3 | 2 | 5 |
| 2018 | 4 | 2 | 6 |
| 2019 | 5 | 0 | 5 |
| 2020 | 1 | 4 | 5 |
| 2021 | 2 | 1 | 3 |
| 2022 | 2 | 4 | 6 |
| 2023 | 3 | 3 | 6 |
| 2024 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "von Willebrand Factor" by people in Profiles.
-
Recommendations on Monitoring and Replacement of Antithrombin, Fibrinogen, and Von Willebrand Factor in Pediatric Patients on Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference. Pediatr Crit Care Med. 2024 Jul 01; 25(7 Suppl 1):e35-e43.
-
The effect of ADAMTS13 on graft-versus-host disease. J Cell Mol Med. 2024 Jul; 28(13):e18457.
-
The Impact of Acute Exercise on Hemostasis and Angiogenesis Mediators in Patients With Continuous-Flow Left Ventricular Assist Devices: A Prospective Observational Pilot Study. ASAIO J. 2025 Jan 01; 71(1):11-20.
-
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma. Blood Coagul Fibrinolysis. 2024 Jul 01; 35(5):256-264.
-
A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels. Blood. 2024 05 02; 143(18):1845-1855.
-
Microvascular activation and exocytosis after exposure to the serum from mismatched recipients by using donor microvascular cultures. Transpl Immunol. 2024 02; 82:101963.
-
Initial von Willebrand factor antigen values in adolescent females predict future values. Haemophilia. 2023 Nov; 29(6):1547-1555.
-
Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia. Int J Mol Sci. 2023 Jul 22; 24(14).
-
Force-induced biphasic regulation of VWF cleavage by ADAMTS13. Thromb Res. 2023 09; 229:99-106.
-
Heat-inactivated Factor B inhibits alternative pathway fluid-phase activation and convertase formation on endothelial cell-secreted ultra-large von Willebrand factor strings. Sci Rep. 2023 04 08; 13(1):5764.